SEC 13F Intelligence

Miller Value Partners, LLC / HALO

Miller Value Partners, LLC’s Halozyme Therapeutics Inc Position

Does Miller Value Partners, LLC own Halozyme Therapeutics Inc (HALO)? Not currently — the last reported position was 20.0K shares worth $355,000 in Q4 2019; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$355,000
Q4 2019
Shares
20.0K
% of Portfolio
+0.01%
Quarters Held
5
position exited

Position History HALO

Reported value by quarter
Q4 ’18: $293,000Q4 ’18Q1 ’19: $322,000Q1 ’19Q2 ’19: $344,000Q2 ’19Q3 ’19: $310,000Q3 ’19Q4 ’19: $355,000Q4 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q4 201920.0K$355,000+0.01%
Q3 201920.0K$310,000+0.01%
Q2 201920.0K$344,000+0.01%
Q1 201920.0K$322,000+0.01%
Q4 201820.0K$293,000+0.01%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Miller Value Partners, LLC’s full portfolio or all institutional holders of HALO.